Trials in New York, New York
Here are the top 10 medical studies for alzheimer's disease in New York, New York
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Lecanemab for Alzheimer's Disease
Recruiting1 awardPhase 3
Toronto, Ontario
This trial is testing lecanemab, a drug aimed at improving memory and thinking skills in people with early signs of Alzheimer's disease. The drug works by reducing amyloid plaques in the brain, which are believed to contribute to Alzheimer's. Researchers want to see if lecanemab is effective over several years.
Monoclonal Antibodies
Donanemab for Early Alzheimer's Disease
Recruiting1 awardPhase 3
Washington, District of Columbia
This trial is testing donanemab, a drug for early Alzheimer's disease. It targets people with early symptoms and specific brain changes. The drug helps remove harmful proteins from the brain, potentially slowing down or improving symptoms.
Monoclonal Antibodies
Investigational Alzheimer's Drugs for Early Onset Alzheimer's Disease
Recruiting0 awardsPhase 2 & 3
Toronto, Ontario
This trial tests two drugs, lecanemab and E2814, in people with a genetic mutation that causes Alzheimer's disease. Lecanemab helps remove harmful protein clumps from the brain, while E2814 prevents harmful protein tangles from forming. The goal is to see if these drugs can slow down or improve symptoms of Alzheimer's.
Melatonin Receptor Agonist
Piromelatine for Alzheimer's Disease
Recruiting0 awardsPhase 2 & 3
Toronto, Ontario
This trial tests piromelatine, a pill taken before bed, in people with mild Alzheimer's who lack a specific genetic variation. The goal is to see if it can improve brain function and slow down dementia progression.
Trials With No Placebo
Procedure
Home Sleep Apnea Testing for Cognitive Impairment
Recruiting1 award4 criteria
Toronto, Ontario
This trial is investigating whether home sleep apnea testing is more effective than in-laboratory polysomnography in diagnosing obstructive sleep apnea in patients with vascular cognitive impairment or Alzheimer's disease.
Behavioral Intervention
Integrated Care for Agitation in Alzheimer's Disease
Recruiting1 award
Toronto, Ontario
This trialwill study an Integrated Care Pathway to treat aggression & agitation in Alzheimer's, using psychotropic medications & non-pharmacological interventions, to assess its efficacy, impact on inappropriate medication use, & caregiver burden.
Electrical Brain Stimulation
Exercise + tDCS for Alzheimer's Disease
Recruiting1 award
Toronto, Ontario
This trial looks at whether combining exercise with transcranial direct current stimulation, a type of brain stimulation, can help improve memory in people with mild cognitive impairment or Alzheimer's disease.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.